Table 1 : Patients characteristics of the 2 groups.

	Group 1 BCG (n= 40)		Group II Docetaxel (n=42)		P-value
	No.	%	No.	%
Sex
Male	38	95.0	38	90.5	0.717
Female	2	5.0	4	9.5
Age: (years)
Mean±SD	55.80 ± 11.33		58.90 ± 11.44		0.294
Median (Range)	56.0 (37.0-75.0)		60.0 (39.0- 79.0)
Grade:
Grade I	7	17.5	12	28.6	0.193
Grade II	6	15.0	2	4.8
Grade III	27	67.5	28	66.7
Multiplicity:
Yes	5	12.5	10	23.8	0.185
No	35	87.5	32	76.2
Risk
Intermediate	12	30.0	14	33.3	0.746
High	28	70.0	28	66.7
Site:
Anterior wall	6	15.0	10	23.8	0.314
Posterior wall	24	60.0	22	52.4	0.860
Left wall	7	17.5	6	14.3	0.690
Right wall	3	7.5	0	0.0	0.223
Posterior & Right wall	0	0.0	2	4.8	0.496
Posterior & Ant wall	0	0.0	2	4.8	0.496
Shape:
Papillary	35	87.5	36	85.7	0.746
Non-papillary	5	12.5	6	14.3